TY  - GEN
AU  - Macquart-Moulin,G
AU  - Viens,P
AU  - Palangié,T
AU  - Bouscary,M L
AU  - Delozier,T
AU  - Roché,H
AU  - Janvier,M
AU  - Fabbro,M
AU  - Moatti,J P
TI  - High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
SN  - 0732-183X
PY  - 2000///0713
KW  - Activities of Daily Living
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Breast Neoplasms
KW  - Emotions
KW  - Feasibility Studies
KW  - Female
KW  - Filgrastim
KW  - Follow-Up Studies
KW  - Granulocyte Colony-Stimulating Factor
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Interpersonal Relations
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Patient Acceptance of Health Care
KW  - Pilot Projects
KW  - Quality of Life
KW  - Recombinant Proteins
KW  - Remission Induction
KW  - Social Adjustment
KW  - Statistics, Nonparametric
KW  - Surveys and Questionnaires
KW  - Survival Rate
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2000.18.4.754
ER  -